Rakesh Jhunjhunwala’s Latest Portfolio, Holdings, News – 2018

Started at the age of only 12, Jhunjhunwala is creating a havoc in Indian trade industry since then. A well-experienced share market expert that possesses almost everything that needs to be a perfect stock investor.

Rakesh Jhunjhunwala, aged 57 is successful equity investor and trader in India. Recently Forbes reported that he is 53rd richest citizen of India, with a net worth of USD 2.8 Billion. He is professionally a Chartered Accountant that practice in his own firm as to manage his own portfolio being a partner in asset management firm. Rakesh along with his wife Rekha Jhunjhunwala owns firm naming “Rare Enterprise”.

Often referred as Indian Warren Buffet, the year 2017 was very good for this stock guru. The one-third of Rakesh Jhunjhunwala’s portfolio stocks doubled in value, and half of them delivered better returns above two times of the Bombay Stock Exchange’s Sensex. Can you believe that? No, but it’s the fact.

When 30 pack Bombay Stock Exchange Sensex rose to 26%, minimum 20 of his portfolio stocks have gained a rise up to 280%.

Followers or admirer of Rakesh’s success always asks for his strategies or the key to success in stock trading. Here’s the answer to all their questions. The table given below discloses all the information about his investments in stocks with its value. It is updated up till July 2018

His recent investments

The investments of Rakesh Jhunjhunwala in just 10 stocks are worth above ₹9,200 crores which makes him the biggest individual investor at Dalal Street with a net worth of $3.2 Billion. He made investments in stocks of Fortis Healthcare, Prakash Industries,and JP Associates. Companies which are either crippled by this huge debt or regulatory surveillance.

Prakash Industries was mentioned among the 331 suspected shell companies against whom SEBI had started a trading ban. The SAT i.e. Securities Appellate Tribunal then lifted this ban.

Singh Brothers of Fortis Healthcare and Daiichi are locked in litigation over claims of ₹3,500 crore in damages and interest by the latter. JP Associates is still fighting with a huge debt on their balance sheet.

Rakesh Jhunjhunwala recently bought a stake in gaming organization Nazara Technologies of ₹180 crore in his first ever bet on Digital Industry.

Geojit BNP Paribas is another stock in his portfolio. Paribas has delivered an exponential 206% return in 2017. Shares of another share brokerage firm, Edelweiss Securities have risen over 198% and Rakesh Jhunjhunwala owns 1.05% share in this broking firm, which has just acquired their business from Religare Enterprises.

The leading bag maker VIP Industries also giftedJhunjhunwala with 206% return.

Shares of leading watch manufactures and industry leaders Titan Company,which is the crown of the Jhunjhunwala portfolio, have risen 165% last year. Titan has been Jhunjhunwala’s preferred pick. Rakesh and his wife, Rekha Jhunjhunwala holds above 8% stake in Titan together, which was worth over ₹ 6,000crores in last year’s December.

Aptech, ION, Autoline and Escorts are some of the other firms in the portfolio of Jhunjhunwalathat gave over 100% returns in 2017.

Sept Quarter Rejig

In 2017, September quarter shareholding figure showed that Rakesh Jhunjhunwala sequentially cuts his stake at Titan, Aurobindo Pharma, TV18 Broadcast, Jubilant Life Sciences, Federal Bank and JP Associates. Even if they were rising, Jhunjhunwala trimmed his share in Vysya Bank and Prakash Industries.

Rakesh and his wife held over 7 crore shares or fairly 8.06% in Titan at the end of September 2017. 20 basis points lower than their entire holding at the end of June quarter. Jhunjhunwala had 1.12% share in Aurobindo Pharma as of June 30, 2017, which he lowered to 1%, a minimum of the amount any company to name the investor in shareholding data. JP Associates is another firm where he had just above 1%, 1.03% to be precise as of June 30, 2017. Still, his name didn’t show in September 2017’s shareholding data.

Our content is delivered by a team of authors and contributors from multidisciplinary backgrounds, experiences, and various expertise. Together we deliver content which adds value to your life and we serve our readers only with authentic content.